SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.42 |
| Enterprise Value ($M) | -0.57 |
| Book Value ($M) | -0.97 |
| Book Value / Share | -0.49 |
| Price / Book | -2.49 |
| NCAV ($M) | -1.44 |
| NCAV / Share | -0.73 |
| Price / NCAV | -1.68 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.08 |
| Return on Equity (ROE) | -3.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.77 |
| Current Ratio | 0.77 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.91 |
| Assets | 5.38 |
| Liabilities | 6.35 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | Lind Global Fund II LP | 0.00 | -100.00 | |
| 13G/A | Dellora Investments LP | 0.00 | -100.00 | |
| 13G/A | Schonfeld Strategic Advisors LLC | 0.18 | -99.75 | |
| 13G/A | Altium Capital Management LP | 4.99 | -53.70 | |
| 13G/A | Acorn Bioventures, L.p. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 33,684 | 235,144 | 14.32 | |
| 27,085 | 334,559 | 8.10 | |
| 20,777 | 270,583 | 7.68 | |
| 121,087 | 439,258 | 27.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CTXR – Citius Pharmaceuticals, Inc. | CUE – Cue Biopharma, Inc. |
| CVKD – Cadrenal Therapeutics, Inc. | CYCN – Cyclerion Therapeutics, Inc. |
| CYRX – Cryoport, Inc. |